| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.6773 | 
      | Human Intestinal Absorption | HIA+ | 0.6527 | 
      | Caco-2 Permeability | Caco2- | 0.6758 | 
      | P-glycoprotein Substrate | Substrate | 0.6495 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8662 | 
                                                     | Non-inhibitor | 0.8620 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9309 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6325 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7804 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9081 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6450 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7965 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9452 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9598 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9325 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8310 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8767 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9589 | 
                                                                    | Non-inhibitor | 0.8765 | 
      | AMES Toxicity | Non AMES toxic | 0.6536 | 
      | Carcinogens | Non-carcinogens | 0.9497 | 
      | Fish Toxicity | High FHMT | 0.9563 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9824 | 
      | Honey Bee Toxicity | High HBT | 0.6787 | 
      | Biodegradation | Not ready biodegradable | 0.8770 | 
      | Acute Oral Toxicity | III | 0.6807 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5452 |